CN Patent

CN106795515B — 用于经由rna干扰调控基因表达的组合物和方法

Assigned to Monsanto Technology LLC · Expires 2021-06-08 · 5y expired

What this patent protects

本公开提供了用于经由RNA介导的沉默调控基因表达的组合物和方法。本公开还提供了优化将dsRNA分子加工成小RNA双链体的组合物和方法。本公开还提供了改善dsRNA分子在产生期望的小RNA和促进目标基因的沉默方面的效率的组合物和方法。

USPTO Abstract

本公开提供了用于经由RNA介导的沉默调控基因表达的组合物和方法。本公开还提供了优化将dsRNA分子加工成小RNA双链体的组合物和方法。本公开还提供了改善dsRNA分子在产生期望的小RNA和促进目标基因的沉默方面的效率的组合物和方法。

Drugs covered by this patent

bendamustine-hydrochloride (BENDAMUSTINE HYDROCHLORIDE)

Patent Metadata

Patent number: CN106795515B
Jurisdiction: CN
Classification: —
Expires: 2021-06-08
Drug substance claim: No
Drug product claim: No
Assignee: Monsanto Technology LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.